Efficacy and Safety of Punarnavadi Mandura and Dadimadi Ghrita Vs Standard Care in Adolescents with Iron Deficiency Anemia in Improving Hemoglobin Level, Functional Gut well-being and Cognitive Performance- A Randomized Active Controlled Trial

Central Council for Research in Ayurvedic Sciences,0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•Exclusion Criteria:
•1. Subjects suffering from any other type of anemia such as Anemia of chronic diseases, megaloblastic anemia, sideroblastic anemia, hemolytic anemia
•2. Any inherited blood disorder such as Thalassemia, aplastic anemia, sickle cell anemia
•3. A history or a diagnosis of Acute myelogenous or lymphoblastic leukemia, Multiple myeloma, Primary or secondary myelodysplastic syndrome, hemochromatosis
•4. Use of any iron-containing drugs or treatment for anemia during the last 3 months.
•5. Known hypersensitivity to oral iron or any component of the trial intervention
•6. Participants with conditions necessitating parenteral iron therapy such as impaired absorption due to diseases such as inflammatory bowel disease, blood loss, etc.
•7. Subjects with evidence of malignancy, chronic infectious diseases, auto immune diseases
•8. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study.
•9.Patients with concurrent serious hepatic disorder or Renal Disorders Severe Pulmonary Dysfunction or cardiac diseases.
•10. Patients who have completed participation in any other clinical trial during the past six (06) months.
•11. Any other condition which the Investigator thinks may jeopardize the study

发起方